Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Boston Scientific Corporation    BSX

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/17/2017 02/21/2017 02/22/2017 02/23/2017 02/24/2017 Date
25.39(c) 25.28(c) 25.16(c) 24.48(c) 24.78(c) Last
7 363 627 7 566 482 7 959 069 41 278 716 13 476 187 Volume
+0.12% -0.43% -0.47% -2.70% +1.23% Change
More quotes
Financials ($)
Sales 2017 8 782 M
EBIT 2017 2 031 M
Net income 2017 1 339 M
Debt 2017 2 817 M
Yield 2017 -
Sales 2018 9 375 M
EBIT 2018 2 285 M
Net income 2018 1 701 M
Debt 2018 1 981 M
Yield 2018 -
P/E ratio 2017 26,49
P/E ratio 2018 20,89
EV / Sales2017 4,16x
EV / Sales2018 3,81x
Capitalization 33 742 M
More Financials
Company
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in a broad range of interventional medical specialties.Its products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive,... 
More about the company
Surperformance© ratings of Boston Scientific Corporat
Trading Rating : Investor Rating :
More Ratings
Latest news on BOSTON SCIENTIFIC CORPORAT
02/24 Goldberg Law PC Announces an Investigation of Boston Scientific Corporation a..
02/24 GLANCY PRONGAY & MURRAY LLP : Commences Investigation on Behalf of Boston Scient..
02/24 BOSTON SCIENTIFIC : New Cross first to fit heart implant
02/24 BOSTON SCIENTIFIC : Hospital first in UK to fit heart implant
02/24 BOSTON SCIENTIFIC : to Participate in 2017 RBC Capital Markets Global Healthcare..
02/24 Khang & Khang LLP Announces an Investigation of Boston Scientific Corporation..
02/23 Law Offices of Howard G. Smith Commences Investigation on Behalf of Boston Sc..
02/23 SQUARE : Boston Scientific and Hormel skid; Square and HP jump
02/23 BOSTON SCIENTIFIC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
02/23 Lundin Law PC Announces an Investigation of Boston Scientific Corporation and..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
02/09 Infineon, Cree warn U.S. might block Wolfspeed deal
02/02 EU probes online sales in electronics, video games, hotels
01/31DJTHERMO FISHER SCIENTIFIC : Earnings, Sales Rise
01/31DJDANAHER : Revenue, Profit Rise
01/30DJEUROPEAN MORNING BRIEFING : Corporate Events
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on BOSTON SCIENTIFIC CORPORAT 
2012All technical elements to short
More Strategies
Latest Tweets
02/25Glg LLC Sells 48,778 Shares of Boston Scientific Co. $BSX  
02/25Boston Scientific Co. $BSX Stake Decreased by Dimensional Fund Advisors LP  
02/25Boston Scientific Co. $BSX Given Buy Rating at Needham & Company LLC  
02/24$BSX Lotus Transcatheter Recalled After Discovery Of Fault And Death Of One P.. 
02/23Boston Scientific loses $1.4B in market cap after heart valve recall
1
More tweets
Qtime:83
News from SeekingAlpha
02/23 Boston Sci's pain is Edwards' gain; shares ahead 3%
02/23 Boston Scientific recalls Lotus Valves due to possible manufacturing defect; ..
02/23 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
02/22 Symetis Follows Its Fellows Into Mitral Valve Technology
02/21 Tracking David Tepper's Appaloosa Management Portfolio - Q4 2016 Update
Advertisement
Chart BOSTON SCIENTIFIC CORPORAT
Duration : Period :
Boston Scientific Corporat Technical Analysis Chart | BSX | US1011371077 | 4-Traders
Full-screen chart
Technical analysis trends BOSTON SCIENTIFIC...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 28,1 $
Spread / Average Target 13%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael F. Mahoney Chairman, President & Chief Executive Officer
Edward Mackey Executive Vice President-Operations
Daniel J. Brennan Chief Financial Officer & Executive Vice President
Keith D. Dawkins Global Chief Medical Officer & Executive VP
Nelda J. Connors Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BOSTON SCIENTIFIC CORP..13.18%33 742
THERMO FISHER SCIENTIF..12.49%62 801
DANAHER CORPORATION9.37%59 542
INTUITIVE SURGICAL, IN..15.95%28 581
PHILIPS-3.22%27 440
ILLUMINA, INC.25.75%23 408
More Results